Abstract: Formation of a layer of material on a surface by atomic layer deposition methods and systems includes using electron bombardment of the chemisorbed precursor.
Abstract: The invention relates to a redox initiator system which allows dental formulations to be cured in acidic medium by way of a free-radical polymerization and which ensures a high level of adhesion of the polymerizing composition to the hard substances of the teeth, namely enamel and, in particular, dentine. The redox initiator system comprises the following constituents: (A) from 14.9 to 50% by weight of a barbituric acid or thiobarbituric acid and/or of a barbituric or thiobarbituric acid derivative, (B) from 30 to 75% by weight of a peroxodisulfate compound and/or peroxodiphosphate compound, (C) from 10 to 35% by weight of a sulfinic acid compound, and (D) from 0.1 to 5% by weight of a copper compound.
Abstract: A graphical user interface for providing real-time process information to a user with regard to a process that is operable under control of one or more process variables includes a scale extending along a gauge axis and one or more bars extending along the gauge axis. Each bar is representative of a set of high and low process limit values for a process variable. Further, the graphical user interface includes a graphical shape displayed along the gauge axis representative of a current value of the process variable. A computer implemented method for providing the graphical user interface is also provided.
Type:
Grant
Filed:
July 1, 1999
Date of Patent:
October 4, 2005
Assignee:
Honeywell Inc.
Inventors:
Gregory A. Jamieson, Stephanie A. E. Guerlain, Peter T. Bullemer
Abstract: The present invention provides methods directed to detecting antibodies that specifically bind to a varicella zoster polypeptide, detecting the presence of a varicella zoster virus in an animal, diagnosing a disease caused by varicella zoster virus, and detecting a varicella zoster virus having a single nucleotide polymorphism in ORF68. The present invention also provides a vaccine composition, a method for producing a modified attenuated varicella zoster virus, isolated polynucleotides, and isolated polypeptides, and viruses.